SCHROEDER, ANDREAS,HELWIG, CHRISTOPH,LOOS, ANJA-HELENA,SCHUELER, ARMIN,FALK, MARTIN,BUTTS, CHARLES,SHEPHERD, FRANCES A.
申请号：
CA2912269
公开号：
CA2912269A1
申请日:
2014.04.14
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The invention is directed to the treatment of lung cancer, preferably non-small cell lung cancer (NSCLC) by means of a combination therapy comprising concurrent chemo-radiotherapy followed by vaccination with a muc-1 lipopetide. The therapy elicits prolonged survival rates compared to a respective therapy including sequential chemo-radiotherapy.
